Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-10 Purchase |
2021-08-12 9:27 pm |
Adagio Therapeutics Inc. | ADGI | Royan Ajay Director 10% Owner |
1,997,000 | $17 | $33,949,000 | 11,241,580 (Indirect) |
View |
| 2021-08-10 Purchase |
2021-08-12 9:25 pm |
Adagio Therapeutics Inc. | ADGI | MITHRIL II LP Mithril II GP LP Mithril II UGP LLC THIEL PETER 10% Owner |
1,997,000 | $17 | $33,949,000 | 11,241,580 (Direct) |
View |
| 2021-08-10 Purchase |
2021-08-12 9:24 pm |
Adagio Therapeutics Inc. | ADGI | MCGUIRE TERRANCE Director |
500,000 | $17 | $8,500,000 | 497,660 (Indirect) |
View |
| 2021-08-10 Purchase |
2021-08-12 9:01 pm |
Adagio Therapeutics Inc. | ADGI | Redmile Group LLC Green Jeremy 10% Owner |
1,470,000 | $17 | $24,990,000 | 3,390,960 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-03-30 6:19 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Polaris Venture Partners V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. Polaris Venture Management Co. V L.L.C. Polaris Partners IX L.P. Polaris Partners GP IX L.L.C. Polaris Healthcare Technology Opportunities Fund L.P. Polaris Healthcare Technology Opportunities Fund GP L.L.C. Flint Jonathan A See Remarks |
0 | $0 | 8,531,700 (Indirect) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:18 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Hershberger Elham Chief Development Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:17 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Hering David Chief Operating Officer |
475,000 | $0 | 475,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:15 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Henderson Jane Chief Financial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:14 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Gerngross Tillman U. Chief Executive Officer 10% Owner |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:13 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Dabora Rebecca Chief Tech and Manuf Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:11 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Connolly Lynn Chief Medical Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 6:10 pm |
N/A 2032-01-29 |
Adagio Therapeutics Inc. | ADGI | Andersen Jill Chief Legal Officer, Secretary |
575,000 | $0 | 575,000 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:10 pm |
N/A 2031-11-18 |
Adagio Therapeutics Inc. | ADGI | Miller Redonda Director |
62,605 | $0 | 62,605 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:07 pm |
N/A 2031-11-18 |
Adagio Therapeutics Inc. | ADGI | MARRAM ELLEN R Director |
62,605 | $0 | 62,605 (Direct) |
View |
Ownership(A) |
2021-11-03 4:48 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Andersen Jill Chief Legal Officer, Secretary |
0 | $0 | 2,700 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-02 6:02 pm |
N/A 2031-10-31 |
Adagio Therapeutics Inc. | ADGI | Andersen Jill Chief Legal Officer, Secretary |
514,863 | $0 | 514,863 (Direct) |
View |
| 2021-08-10 Conversion |
2021-08-12 9:27 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Royan Ajay Director 10% Owner |
11,093,496 | $0 | 11,241,580 (Indirect) |
View |
| 2021-08-10 Conversion |
2021-08-12 9:25 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | MITHRIL II LP Mithril II GP LP Mithril II UGP LLC THIEL PETER 10% Owner |
11,093,496 | $0 | 11,241,580 (Direct) |
View |
| 2021-08-10 Conversion |
2021-08-12 9:24 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | MCGUIRE TERRANCE Director |
9,638,040 | $0 | 497,660 (Indirect) |
View |
| 2021-08-10 Conversion |
2021-08-12 9:23 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Gerngross Tillman U. Chief Executive Officer 10% Owner |
31,032,840 | $0 | 27,845,995 (Indirect) |
View |
| 2021-08-10 Conversion |
2021-08-12 9:22 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Adimab LLC 10% Owner |
31,032,840 | $0 | 27,845,995 (Direct) |
View |
Ownership(A) |
2021-08-12 9:21 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | MITHRIL II LP Mithril II GP LP Mithril II UGP LLC THIEL PETER 10% Owner |
0 | $0 | 9,244,580 (Direct) |
View |
| 2021-08-10 Conversion |
2021-08-12 9:01 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Redmile Group LLC Green Jeremy 10% Owner |
1,920,960 | $0 | 3,390,960 (Indirect) |
View |
| 2021-08-05 Option Award |
2021-08-09 7:59 pm |
N/A 2031-08-04 |
Adagio Therapeutics Inc. | ADGI | Mayer Howard Director |
35,593 | $0 | 35,593 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 7:58 pm |
N/A 2031-08-04 |
Adagio Therapeutics Inc. | ADGI | MCGUIRE TERRANCE Director |
35,593 | $0 | 35,593 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 7:56 pm |
N/A 2031-08-04 |
Adagio Therapeutics Inc. | ADGI | Royan Ajay Director 10% Owner |
35,593 | $0 | 35,593 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 7:55 pm |
N/A 2031-08-04 |
Adagio Therapeutics Inc. | ADGI | Russo Rene Director |
35,593 | $0 | 35,593 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 7:54 pm |
N/A 2031-08-04 |
Adagio Therapeutics Inc. | ADGI | WYZGA MICHAEL S Director |
71,186 | $0 | 71,186 (Direct) |
View |
Ownership |
2021-08-05 9:39 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | MCGUIRE TERRANCE Director |
0 | $0 | 8,031,700 (Indirect) |
View |
Ownership |
2021-08-05 9:28 pm |
N/A 2031-06-29 |
Adagio Therapeutics Inc. | ADGI | Shah Anand Director |
0 | $0 | 125,380 (Direct) |
View |
Ownership |
2021-08-05 9:26 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Russo Rene Director |
0 | $0 | 1,985,295 (Direct) |
View |
Ownership |
2021-08-05 9:26 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Royan Ajay Director 10% Owner |
0 | $0 | 9,244,580 (Indirect) |
View |
Ownership |
2021-08-05 9:24 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | MITHRIL II LP 10% Owner |
0 | $0 | 9,244,580 (Indirect) |
View |
Ownership |
2021-08-05 9:23 pm |
N/A 2031-01-12 |
Adagio Therapeutics Inc. | ADGI | Mayer Howard Director |
0 | $0 | 215,150 (Direct) |
View |
Ownership |
2021-08-05 9:22 pm |
N/A 2031-06-29 |
Adagio Therapeutics Inc. | ADGI | Heyman Tomas J. Director |
0 | $0 | 125,380 (Direct) |
View |
Ownership |
2021-08-05 9:21 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Hershberger Elham Chief Development Officer |
0 | $0 | 1,112,800 (Direct) |
View |
Ownership |
2021-08-05 9:20 pm |
N/A 2030-09-29 |
Adagio Therapeutics Inc. | ADGI | Hering David Chief Operating Officer |
0 | $0 | 1,282,310 (Direct) |
View |
Ownership |
2021-08-05 9:18 pm |
N/A 2031-01-12 |
Adagio Therapeutics Inc. | ADGI | Henderson Jane Chief Financial Officer |
0 | $0 | 1,546,775 (Direct) |
View |